The EMA’s recommendation follows evidence that the targeted therapy improves progression-free survival in patients whose ...

The EMA’s assessment confirms the treatment matches the reference drug in quality and performance, potentially expanding ...

Regulators upheld their earlier decision after reexamination, saying the substance does not meet the criteria for new active ...

The recommendation follows results showing markedly longer time to diagnosis of stage 3 T1D in treated patients, a condition ...

Karina Volkova trains in a clinic using a temporary permit that expires in 2027, giving her a narrow window to clear all ...

EU regulator says treatment could fill major gap for patients who lack a suitable stem cell donor and leads to sharp drops in ...

Pertuzumab-dpzb is now considered an interchangeable biosimilar to pertuzumab as part of treatment combinations in multiple ...

With indications that ‘“dialysis begets dialysis”’ and can obscure kidney function improvement, a novel trial shows notable ...

An analysis of a German multicentre study reveals that women are more likely than men to receive inappropriate diagnostic ...

In Parkinson’s disease, early signs such as constipation, loss of smell, and REM sleep disturbance may appear up to a decade ...

Prophylactic closure of defects after endoscopic submucosal dissection of the colon reduces delayed bleeding and may lower ...

A new digital wound care module assists clinicians in selecting appropriate dressings and generating standardized treatment ...